Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Potassium bicarbonate [USP]

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Accepts Sibnayal MAA For dRTA Treatment In US
    FDA Accepts Sibnayal MAA For dRTA Treatment In US

    19 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-19/advicenne-fda-has-accepted-for-review-the-marketing-authorization-application-for-sibnayal-in-the

    PHARMIWEB
    19 Jan 2026
    Share Share
    FDA Accepts Sibnayal NDA for dRTA Treatment in the US
    FDA Accepts Sibnayal NDA for dRTA Treatment in the US

    19 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-19/advicenne-fda-has-accepted-for-review-the-marketing-authorization-application-for-sibnayal-in-the

    PHARMIWEB
    19 Jan 2026
    Share Share
    EU Renews Sibnayal Authorization for Advicenne
    EU Renews Sibnayal Authorization for Advicenne

    12 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-12/advicenne-has-successfully-renewed-the-marketing-authorization-of-sibnayal-in-european-union

    PHARMIWEB
    12 Jan 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.